Product
SHEN211
Aliases
SHEN211 placebo tablets, SHEN211 tablets, SHEN211 Tablets, Test group
2 clinical trials
2 indications
Indication
Phase IIndication
COVID-19Clinical trial
To Evaluate the Safety, Tolerability, Pharmacokinetics and Food Effects of SHEN211 Tablet in Healthy Subjects With Fasting Single or Multiple Oral AdministrationStatus: Recruiting, Estimated PCD: 2024-04-02
Clinical trial
A Randomized, Double-blind, Placebo-controlled, Multicenter Phase II Clinical Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of SHEN211 Tablets in the Treatment of Patients With Mild and Moderate Novel Coronavirus InfectionStatus: Not yet recruiting, Estimated PCD: 2024-08-01